Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus
โ Scribed by Murray B. Urowitz; Anoja Anton; Dominique Ibanez; Dafna D. Gladman
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2011
- Tongue
- English
- Weight
- 59 KB
- Volume
- 63
- Category
- Article
- ISSN
- 2151-464X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
To characterize the initial events in anti-Ro production by a patient with systemic lupus erythematosus, in whom this autoantibody is developing. Methods. The immune response to the Ro ribonucleoprotein and other autoantigens were studied by enzyme-linked immunosorbent assay for IgG and IgM, by iso
have excluded this index from our nutritional assessment as its use may not be valid in patients with inflammatory joint disease. In addition, we have found significantly lower serum levels of albumin, transferrin, zinc, and folic acid in the RA patients, 12 (30%) of whom had combined anthropometri
## Objective: To examine the prevalence, clinical associations, and pathogenic role of autoantibodies to c-mpl, the thrombopoietin (tpo) receptor, in patients with systemic lupus erythematosus (sle). ## Methods: Sera from 69 sle patients, 84 patients with idiopathic thrombocytopenic purpura (itp)
## Abstract This report describes a patient with active systemic lupus erythematosus (SLE) who evidenced severe bleeding consequent to a profound and isolated reduction in plasma factor II (prothrombin) activity. Absence of the factor is documented by immunologic means and its return after corticos